This year’s ISPE Annual Meeting & Expo will be full of great, thought-provoking content for the Investigational Products Community of Practice.
The theme “Driving Innovation to Advance Patient Therapies” aligns with the Investigational Products track focused on supply chain agility. From driving efficiency in demand modeling through agility in distribution, the topics will invoke discussion amongst Investigation Products professionals as to how we can innovate to meet the demands of the future.
The End to End Supply Chain Management track kicks off on Sunday with the session “Artificial Intelligence: Taking the Mystery Out of Supply Chain Planning”. This session will be followed by a discussion on how to “Leverage Expiry Date Material Planning to Reduce Waste.” Additional sessions that will be featured during the End-to-End Supply Chain Management track include:
We look forward to seeing and networking with all of you at our annual Investigational Products Community of Practice event on Monday Night. It promises to be an exciting evening of Halloween fun as we cruise on a casino game ship reuniting old acquaintances and meeting new ones to continue to strengthen our community.
To learn more about the 2017 ISPE Annual Meeting & Expo and the End-to-End Supply Chain Management sessions offered during the conference, visit the conference website.
Stability sampling and testing are key to ensuring that products maintain safety, identity, strength, purity, and quality throughout their claimed shelf life. It is also a regulatory requirement per ICH Q5. However, storing product samples in different environmental conditions, testing those samples for three to five years (or more) after initial manufacture, and properly analyzing and...
ISPE hosted more than 450 attendees in person and virtually for the 2024 ISPE Aseptic Conference in Vienna, Austria. Keynotes and education sessions provided a comprehensive overview of key topics and trends...
Biopharmaceutical facility design is a critical aspect of the industry. Overall cost pressures in the global health system, regional requirements to deploy manufacturing rather than centralize manufacturing in one location, technology enhancements in cell biology and format, flexibility to accommodate multi-product campaigns with different production schedules, and speed-to-market are among...